Protein Dynamics: Proteins acting out of (dis)order

A disordered region at the N-terminus of the glucocorticoid receptor can fine tune how cells respond to a hormone via an allosteric mechanism.
  1. David Eliezer  Is a corresponding author
  1. Weill Cornell Medical College, United States

For a long time it was thought that proteins only worked after folding into specific three-dimensional shapes (Anfinsen, 1973). However, disordered proteins – flexible proteins that lack a well-defined shape or structure – are found in almost all organisms, and our understanding of how protein disorder is coupled to protein function continues to evolve.

Disordered proteins can bind to other well-folded proteins and fold around them, thus gaining structure while executing their functions. Alternatively, disordered proteins can attach to other proteins via short, typically linear motifs, influencing the target protein while remaining largely flexible and unstructured (Mittag et al., 2010; Babu et al., 2012; Van Roey et al., 2014). However, it was commonly assumed that disordered proteins were unable to exhibit allostery, or “action at a distance”. Now, in eLife, Vincent Hilser and colleagues at Johns Hopkins University and the University of Houston report that disordered proteins can show allostery, and that alterations in the disordered regions of a protein can tune this effect to regulate the protein’s function (Li et al., 2017).

Allostery involves a change made at one location in a protein (the so-called allosteric site) exerting a functional effect at a distant region of the same protein (the functional site). Intuitively, we like to think of allostery as being transmitted via a physical connection between the allosteric site and the functional site: that is, pulling or pushing at the initial site is ‘felt at the distant site. In order for such a signal to be transmitted, we also assume that the connection between the sites must be rigid (Figure 1A and B). If the connection is instead flexible and dynamic, as in a disordered protein, it would seem that perturbation at one site cannot be effectively communicated to a distant location. As is often the case, however, our intuition based on the macroscopic physical world can lead us astray when considering things on the molecular scale.

Allosteric coupling in well-structured and flexible proteins.

(A, B) Cartoon illustrations of two rigidly linked well-structured domains in an assumed mechanical model. The allosteric site is on the right, above its ligand (black downward arrow), and the functional site is on the left, below its binding partner (black upward arrow). Binding at the allosteric site pivots the rigid linker around a fulcrum; this applies a force to the domain containing the functional site, which binds to its partner. (C) Cartoon illustration of allosteric coupling between a structured domain (left) and a disordered domain (right). The flexibility of the disordered region means that a force is not directly applied to the structured domain when the disordered region binds to its binding partner (black downward arrows). (D) Nevertheless, binding of the disordered region alters the energetics of the system in a way that makes binding at the functional site more favorable. In this illustrative case, we simulate these energetics by placing our mechanical system in a water bath (blue dashed line). By binding to its ligand (bottom right), the disordered domain raises the water level in the bath (blue upward arrow in C), indirectly causing the domain containing the functional site to float closer to its target. In real proteins, the energetic coupling is mediated by the rebalancing of the ensemble of different possible states that occurs when the allosteric site binds to its ligand (see Hilser and Thompson, 2007).

Hilser’s earlier work has shown that it may be difficult or impossible to understand the behavior of a protein in the context of a single direct link between sites of action and effect. Instead, it must be understood in terms of a constantly changing ensemble of different protein structures, in which changes in the stability of one site influence the entire ensemble in a way that can alter the likelihood of changes at a distant site (Hilser et al., 1998). The beauty of this theory is that it applies equally to well-structured proteins and to disordered proteins. Indeed, over 10 years ago, Hilser used this approach to predict that disordered protein regions could exert allosteric effects on other protein domains (Figure 1C and D; Hilser and Thompson, 2007).

Since this original prediction, a handful of high profile reports have documented allostery in disordered proteins, including in the oncoprotein E1A (Ferreon et al., 2013), and in a bacterial antitoxin (Garcia-Pino et al., 2010). Now, Hilser and colleagues, including Jing Li as first author, have focused on a protein known as the glucocorticoid receptor, a critical transcription factor that controls how cells respond to steroid hormones. Under different conditions, cells will produce versions of this receptor that differ only in the length of a disordered region at one end of the protein. Li et al. show that these different forms of the glucocorticoid receptor also alter the strength of the hormonal response to differing extents. This is possible because the disordered region enhances the hormonal response by enhancing DNA binding at a site located in an entirely different part of the protein. Paradoxically, the same disordered region also inhibits the hormonal response by directly regulating another domain, the F-domain. Depending on the specific form of the N-terminal disordered protein region, the sum of these two opposing effects is different, allowing the cell to fine tune its response to the presence of the hormone.

These findings imply that disordered proteins may have certain advantages for allosteric regulation compared with well-structured proteins. Producing different forms of well-structured proteins is challenging, because splicing new protein segments into an existing structure, or excising segments out of one, may be difficult to do while maintaining the protein’s architecture. In contrast, disordered proteins are essentially unconstrained by structure. As such, they can easily tolerate the insertion or removal of segments to generate distinct forms (Romero et al., 2006). Li et al. show that cells producing distinct forms of a specific disordered protein region, featuring different allosteric properties, exhibit different hormonal responses. More broadly, their work implies that altering a disordered region of a protein is a particularly flexible approach by which cells and organisms can fine tune allosteric regulation of critical biological processes. It can therefore be expected that this mechanism will prove to be widespread and important throughout biology.

References

Article and author information

Author details

  1. David Eliezer

    David Eliezer is in the Department of Biochemistry, Weill Cornell Medical College, New York, United States

    For correspondence
    dae2005@med.cornell.edu
    Competing interests
    No competing interests declared
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-1311-7537

Publication history

  1. Version of Record published:

Copyright

© 2017, Eliezer

This article is distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 2,562
    views
  • 248
    downloads
  • 5
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. David Eliezer
(2017)
Protein Dynamics: Proteins acting out of (dis)order
eLife 6:e32762.
https://doi.org/10.7554/eLife.32762

Further reading

    1. Biochemistry and Chemical Biology
    2. Structural Biology and Molecular Biophysics
    Yamato Niitani, Kohei Matsuzaki ... Michio Tomishige
    Research Article

    The two identical motor domains (heads) of dimeric kinesin-1 move in a hand-over-hand process along a microtubule, coordinating their ATPase cycles such that each ATP hydrolysis is tightly coupled to a step and enabling the motor to take many steps without dissociating. The neck linker, a structural element that connects the two heads, has been shown to be essential for head–head coordination; however, which kinetic step(s) in the chemomechanical cycle is ‘gated’ by the neck linker remains unresolved. Here, we employed pre-steady-state kinetics and single-molecule assays to investigate how the neck-linker conformation affects kinesin’s motility cycle. We show that the backward-pointing configuration of the neck linker in the front kinesin head confers higher affinity for microtubule, but does not change ATP binding and dissociation rates. In contrast, the forward-pointing configuration of the neck linker in the rear kinesin head decreases the ATP dissociation rate but has little effect on microtubule dissociation. In combination, these conformation-specific effects of the neck linker favor ATP hydrolysis and dissociation of the rear head prior to microtubule detachment of the front head, thereby providing a kinetic explanation for the coordinated walking mechanism of dimeric kinesin.

    1. Structural Biology and Molecular Biophysics
    Christopher T Schafer, Raymond F Pauszek III ... David P Millar
    Research Article

    The canonical chemokine receptor CXCR4 and atypical receptor ACKR3 both respond to CXCL12 but induce different effector responses to regulate cell migration. While CXCR4 couples to G proteins and directly promotes cell migration, ACKR3 is G-protein-independent and scavenges CXCL12 to regulate extracellular chemokine levels and maintain CXCR4 responsiveness, thereby indirectly influencing migration. The receptors also have distinct activation requirements. CXCR4 only responds to wild-type CXCL12 and is sensitive to mutation of the chemokine. By contrast, ACKR3 recruits GPCR kinases (GRKs) and β-arrestins and promiscuously responds to CXCL12, CXCL12 variants, other peptides and proteins, and is relatively insensitive to mutation. To investigate the role of conformational dynamics in the distinct pharmacological behaviors of CXCR4 and ACKR3, we employed single-molecule FRET to track discrete conformational states of the receptors in real-time. The data revealed that apo-CXCR4 preferentially populates a high-FRET inactive state, while apo-ACKR3 shows little conformational preference and high transition probabilities among multiple inactive, intermediate and active conformations, consistent with its propensity for activation. Multiple active-like ACKR3 conformations are populated in response to agonists, compared to the single CXCR4 active-state. This and the markedly different conformational landscapes of the receptors suggest that activation of ACKR3 may be achieved by a broader distribution of conformational states than CXCR4. Much of the conformational heterogeneity of ACKR3 is linked to a single residue that differs between ACKR3 and CXCR4. The dynamic properties of ACKR3 may underly its inability to form productive interactions with G proteins that would drive canonical GPCR signaling.